Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pieris Pharmaceuticals Inc (PIRS)

Pieris Pharmaceuticals Inc (PIRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pieris Pharmaceuticals Inc 225 Franklin Street 26th Floor Boston MA 02110 USA

www.pieris.com Employees: 50 P: 857-246-8998

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.

Key Statistics

Overview:

Market Capitalization, $K 17,955
Enterprise Value, $K 555
Shares Outstanding, K 1,320
Float, K 1,236
% Float 93.61%
Short Volume Ratio 0.26
% of Insider Shareholders 6.39%
% of Institutional Shareholders 40.11%
Annual Net Income, $ -24,540 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,590 K
EBIT, $ -25,790 K
EBITDA, $ -23,890 K
3-Year Return -95.01%
5-Year Return -94.88%
5-Year Revenue Growth 47.11%
5-Year Earnings Growth 76.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.19 on 11/13/24
Next Earnings Date 04/04/25
Earnings Per Share ttm -19.51
EPS Growth vs. Prev Qtr 20.65%
EPS Growth vs. Prev Year 75.11%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-80 on 04/23/24

PIRS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -80.93%
Return-on-Assets % -59.55%
Profit Margin % -57.32%
Debt/Equity 0.00
Price/Sales 0.50
Price/Cash Flow N/A
Price/Book 1.10
Book Value/Share 14.17
Interest Coverage -0.20
60-Month Beta 0.61
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar